BMJ
Almost half of all cancer drug trials show bias and exaggeration
September 19, 2019Research and Development BMJ, Cancer, cancer drug trials
New research on clinical trials between 2014 and 2016 raise “serious concerns about low standards” as over the three year …
Investigation questions Xarelto trial data accuracy
February 4, 2016Medical Communications BMJ, Bayer, INR, Johnson & Johnson, New England Journal of Medicine, Rocket-AF, Xarelto, blood clotting, rivaroxaban
The ROCKET-AF trial, the pivotal trial of the top-selling anti-clotting drug Xarelto, could have been undermined by unreliable results from …
Governments and industry ‘combining to stall drug development’
November 9, 2015Research and Development, Sales and Marketing BMJ, R&D, drug development
Both government and industry practices are responsible for the innovation deficit in the pharmaceutical sector, meaning that “the majority of …
UK doctors urged to curb overtreatment
May 13, 2015Sales and Marketing Academy of Medical Royal Colleges, BMJ, NHS, uk doctors
The UK’s body of medical colleges has launched a new campaign to warn of the dangers of over-treating patients with …
Apple research apps to require ethics board approval
April 30, 2015Sales and Marketing Apple, BMJ, FDA, GP, researchkit
New guidelines will require apps developed for Apple’s ResearchKit health platform to be approved by an independent ethics board. The …
NHS ‘close to breaking point’
April 30, 2015Medical Communications, Sales and Marketing BMJ, Godlee, Kings Fund, NHS, king's fund
England’s NHS is ‘stretched close to breaking point’ and the next five years are likely to be the most challenging …
Government spending on Tamfilu is justified
January 30, 2015Research and Development, Sales and Marketing BMJ, Lancet, Roche, Tamiflu, alltrials, oseltamivir, transparency
The most thorough analysis of Roche’s Tamiflu to date suggests that the controversial treatment can shorten the duration of flu …
Mixed response to EMA data transparency plans
October 3, 2014Medical Communications, Research and Development, Sales and Marketing AbbVie, BMJ, Ben Goldacre, EMA, alltrials, transparency
The European Medicines Agency has passed new rules that will mandate pharma to release more of its clinical trial data …
Should patients be able to email their general practitioner?
September 3, 2014Medical Communications, Sales and Marketing BMJ, GPs, clinicians, econsultations, email
Email consultations with your doctor make better use of their time and are more convenient, or threaten safety and create …
Pradaxa ‘safe’ says Australian regulator
August 6, 2014Research and Development, Sales and Marketing AF, Australia, BMJ, Pradaxa, stroke
Australia’s drug regulator says it will not be updating its safety advice for Boehringer’s Pradaxa despite mounting safety issues around …
BMJ investigation raises new concerns over Pradaxa
July 24, 2014Medical Communications, Research and Development, Sales and Marketing BMJ, Boehringer, Channel 4, Pradaxa, blood, warfarin
An investigation by The BMJ has raised fresh concerns about Boehringer’s top-selling blood thinner Pradaxa (dabigatran) and the regulatory decisions …
Majority of consumed Viagra fake say researchers
July 3, 2014Manufacturing and Production, Sales and Marketing BMJ, ED, Pfizer, Sildenafil, counterfeit, erectile dysfunction, viagra
At least two-thirds of Pfizer’s erectile dysfunction drug Viagra used in the Netherlands may be illegal, researchers are warning. In …
BMJ slams EMA ‘U-turn’
May 30, 2014Medical Communications, Research and Development, Sales and Marketing BMJ, EMA, alltrials, data, transparency
The BMJ has attacked the European Medicines Agency for what it believes is a decision to ‘backtrack’ on public access …
Scrap ‘iniquitous and outdated’ NHS prescription charges
May 15, 2014Sales and Marketing BMJ, NHS, charges, dab, drugs, prescription
The NHS prescription charge is iniquitous and outdated and needs to be scrapped, according to an editorial in the Drug …
Tamiflu stockpiling ‘unjustifiable’ and wasted £424m
April 10, 2014Medical Communications, Research and Development, Sales and Marketing BMJ, Cochrane, Tamiflu, alltrials
Governments around the world may have squandered hundreds of millions of pounds on stockpiling Tamiflu, according to a review by …
